Ö Helvacı1, G Güz5, E Adışen3, S K Cevher4, G Güz5. 1. Department of Nephrology, Yıldırım Beyazıt University, Yenimahalle Training and Research Hospital, Ankara, Turkey. 2. Department of Internal Medicine, , Faculty of Medicine, Gazi University, Ankara, Turkey. 3. Department of Dermatology, Faculty of Medicine, Gazi University, Ankara, Turkey. 4. Department of Nephrology, Numune Training and Research Hospital, Ankara, Turkey. 5. Department of Nephrology, Faculty of Medicine, Gazi University, Ankara, Turkey.
Abstract
BACKGROUND: Hidradenitis suppurativa (HS) is a chronic, disabling skin disease. The estimated prevalence is 1-4 % worldwide. HS is a systemic inflammatory disease and can cause AA amyloidosis. The first report of HS-related amyloidosis dates back to 1966; since then, sporadic cases have been reported. Our work will be the first case series on HS and AA amyloidosis. CASE SERIES: We report eight HS cases complicated with amyloidosis. Six patients were male. The median age was 44 years, and the median disease duration before the amyloidosis diagnosis was 15.5 years. In a mean follow-up of 18 ± 6 months, we achieved favorable renal responses in four of the eight cases (50 %). All cases had a dermatologic response, with four complete and four partial remissions. CONCLUSION: HS is a systemic inflammatory disorder that may cause AA amyloidosis. Aggressive treatment of HS may halt the progression of amyloidosis. HIPPOKRATIA 2020, 24(1): 33-37. Copyright 2020, Hippokratio General Hospital of Thessaloniki.
BACKGROUND:Hidradenitis suppurativa (HS) is a chronic, disabling skin disease. The estimated prevalence is 1-4 % worldwide. HS is a systemic inflammatory disease and can cause AA amyloidosis. The first report of HS-related amyloidosis dates back to 1966; since then, sporadic cases have been reported. Our work will be the first case series on HS and AA amyloidosis. CASE SERIES: We report eight HS cases complicated with amyloidosis. Six patients were male. The median age was 44 years, and the median disease duration before the amyloidosis diagnosis was 15.5 years. In a mean follow-up of 18 ± 6 months, we achieved favorable renal responses in four of the eight cases (50 %). All cases had a dermatologic response, with four complete and four partial remissions. CONCLUSION: HS is a systemic inflammatory disorder that may cause AA amyloidosis. Aggressive treatment of HS may halt the progression of amyloidosis. HIPPOKRATIA 2020, 24(1): 33-37. Copyright 2020, Hippokratio General Hospital of Thessaloniki.
Entities:
Keywords:
AA amyloidosis; Hidradenitis suppurativa; amyloidosis; end-stage renal disease
Authors: Alexa B Kimball; Francisco Kerdel; David Adams; Ulrich Mrowietz; Joel M Gelfand; Robert Gniadecki; Errol P Prens; Joel Schlessinger; Christos C Zouboulis; Hessel H van der Zee; Marie Rosenfeld; Parvez Mulani; Yihua Gu; Susan Paulson; Martin Okun; Gregor B E Jemec Journal: Ann Intern Med Date: 2012-12-18 Impact factor: 25.391
Authors: Prayman T Sattianayagam; Julian D Gillmore; Jennifer H Pinney; Simon D J Gibbs; Ashutosh D Wechalekar; Janet A Gilbertson; Dorota Rowczenio; Philip N Hawkins; Helen J Lachmann Journal: Dig Dis Sci Date: 2013-01-31 Impact factor: 3.199